A Double-blind Randomized Single-center Trial of Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Basiliximab (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 13 Dec 2007 New trial record.